20/20 Biolabs (AIDX) Total Assets: History & Chart

20/20 Biolabs Inc.(AIDX)

Medical - Care Facilities · Gaithersburg, MD

$0.350.00 (0.00%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About 20/20 Biolabs Inc.

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Gaithersburg, MD

14 employees

2020biolabs.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Jonathan Cohen

View full financials

Total Assets

Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.

The latest quarterly total assets is $6.12M with QoQ Growth of +5.51%. Total assets represent the full value of resources controlled by the company, including current assets, property, equipment, and intangible assets.

Total Assets

AIDX Total Assets

$6.12M

Reported quarterly total assets; no daily interpolation. Q2 FY2026 (2026-06-30): $6.12M.

-40.39% over 10Y

AIDX EV/Assets

Full EV/Assets page

EV/Assets

AIDX EV/Assets Chart

0.06x

Current FMP quote-based enterprise value / matching reported total assets Quote observation: 2026-10-06T21:35:36.870Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.

Quarterly Total Assets History

Period	Total Assets	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	$6.12M	+5.51%	+127.06%
Q1 FY2026Period end 2026-03-31	$5.80M	+40.27%	N/A
Q4 FY2025Period end 2025-12-31	$4.14M	+27.72%	+14.51%
Q3 FY2025Period end 2025-09-30	$3.24M	+20.12%	N/A
Q2 FY2025Period end 2025-06-30	$2.70M	N/A	N/A
Q1 FY2025Period end 2025-03-31	$0	(100.00%)	N/A
Q4 FY2024Period end 2024-12-31	$3.61M	N/A	N/A
Q1 FY2024Period end 2024-03-31	$0	(100.00%)	(100.00%)
Q4 FY2023Period end 2023-12-31	$6.37M	+0.00%	(47.87%)
Q3 FY2023Period end 2023-09-30	$6.37M	(27.89%)	(47.87%)
Q2 FY2023Period end 2023-06-30	$8.83M	(17.82%)	(33.35%)
Q1 FY2023Period end 2023-03-31	$10.75M	(12.02%)	N/A
Q4 FY2022Period end 2022-12-31	$12.22M	+0.00%	+18.91%
Q3 FY2022Period end 2022-09-30	$12.22M	(7.82%)	+18.91%
Q2 FY2022Period end 2022-06-30	$13.25M	N/A	N/A
Q1 FY2022Period end 2022-03-31	$0	(100.00%)	N/A
Q4 FY2021Period end 2021-12-31	$10.27M	+0.00%	N/A
Q3 FY2021Period end 2021-09-30	$10.27M	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.